| Pharmaceutical active ingredients: |
| Potassium BicarbonatePotassium Chloride |
| Available forms, composition and doses of Sando-K: |
| Tablets, Effervescent; Oral; Potassium Chloride 0.6 g; Potassium Bicarbonate 0.4 g |
| Sando-K medical category: |
| Human:Replacement preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A12BA51 - Potassium chloride, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisHK Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Kalium Effervescens | Potassium Bicarbonate; Potassium Chloride | GlaxoSmithKline |
| K-Lyte / CL Tablets | Potassium Bicarbonate; Potassium Chloride | Bristol-Myers Squibb |
| Neo-K | Potassium Bicarbonate; Potassium Chloride | Neolab |
| Potassium | Potassium Bicarbonate; Potassium Chloride | Novartis |
| Potassium | Potassium Bicarbonate; Potassium Chloride | Sandoz |
| Liquisorb K | Potassium Bicarbonate; Potassium Chloride; Potassium Phosphate Monobasic | Pfizer |
| Effer-K | Potassium Bicarbonate; Potassium Citrate | Nomax |
| Kalinor | Potassium Bicarbonate; Potassium Citrate | Abbott |
| Klor-Con / EF | Potassium Bicarbonate; Potassium Citrate | Upsher-Smith Laboratories |
| K-Lyte DS | Potassium Bicarbonate; Potassium Citrate | Bristol-Myers Squibb |